This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Bryn Mawr College, Columbia University, Dana-Farber-Cancer Institute Inc.. Active years: 2016-2017.
Company Filing History:
1 out of 13 
1 out of 2,551 
1 out of 1,265 
Years Active: 2016-2017
Title: Innovations by Matthew Le-Khac
Introduction
Matthew Le-Khac is an accomplished inventor based in Brooklyn, NY. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target HIV. With a total of 2 patents, his work has the potential to impact the treatment of viral infections.
Latest Patents
Le-Khac's latest patents include "Small molecule CD4 mimetics and uses thereof" and "CD4-mimetic inhibitors of HIV-1 entry and methods of use thereof." The first patent provides compounds that can be used to create new therapeutic options for patients. The second patent describes small-molecule mimics of CD4 that inhibit HIV-1 entry, showcasing antiviral potency greater than existing treatments. These innovations are crucial in the fight against HIV, as they offer new methods to prevent the transmission and progression of the infection.
Career Highlights
Throughout his career, Matthew Le-Khac has worked with prestigious institutions, including the University of Pennsylvania. His research has focused on developing innovative solutions to combat viral infections, particularly HIV. His contributions to the field have been recognized through his patents and ongoing research efforts.
Collaborations
Le-Khac has collaborated with notable colleagues such as Joseph G Sodroski and Judith M LaLonde. These partnerships have enhanced his research and contributed to the advancement of his innovative work.
Conclusion
Matthew Le-Khac's contributions to medicinal chemistry and his innovative patents position him as a key figure in the fight against HIV. His work continues to pave the way for new therapeutic options that could significantly improve patient outcomes.